(Q42222745)

English

A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses

scientific article published on 18 March 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 October 2017

A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses (English)

1 reference

Europe PubMed Central

18 October 2017

0 references

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24657161%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Yicun Cai

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24657161%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Zhiqiang Ku

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24657161%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Qingwei Liu

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24657161%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Qibin Leng

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24657161%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

0 references

publication date

18 March 2014

1 reference

Europe PubMed Central

18 October 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24657161%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

32

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24657161%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24657161%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

2406-2412

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24657161%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Human enterovirus 71 and hand, foot and mouth disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Challenges to licensure of enterovirus 71 vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Virology, epidemiology, pathogenesis, and control of enterovirus 71.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Genetic diversity of coxsackievirus A16 associated with hand, foot, and mouth disease epidemics in Japan from 1983 to 2003

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

An overview of the evolution of enterovirus 71 and its clinical and public health significance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Construction and characterization of an infectious clone of coxsackievirus A16.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Immunological and biochemical characterization of coxsackie virus A16 viral particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Diseases caused by enterovirus 71 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Fatal infection in an infant associated with Coxsackie virus group A, type 16.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Myocarditis possibly due to Coxsackie group A, type 16, virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

FATAL COXSACKIEVIRUS A16 INFECTION

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Fatal coxsackievirus A-16 pneumonitis in adult

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Rhombencephalitis and coxsackievirus A16

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Emergence of enterovirus 71 "double-recombinant" strains belonging to a novel genotype D originating from southern China: first evidence for combination of intratypic and intertypic recombination events in EV71.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

The global introduction of inactivated polio vaccine can circumvent the oral polio vaccine paradox

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

EV71: an emerging infectious disease vaccine target in the Far East?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Development of enterovirus 71 vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Progress on the research and development of human enterovirus 71 (EV71) vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

A neonatal mouse model of coxsackievirus A16 for vaccine evaluation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Characterization of enterovirus 71 capsids using subunit protein-specific polyclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Neutralizing antibody response in the patients with hand, foot and mouth disease to enterovirus 71 and its clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Survey of enterovirus infections from hand, foot and mouth disease outbreak in China, 2009.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Interference between strains in live virus vaccines, I: Combined vaccination with measles, mumps and rubella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Interference between strains in live virus vaccines. II: Combined vaccination with varicella and measles-mumps-rubella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Evaluation of interferences between dengue vaccine serotypes in a monkey model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Vaccine-induced enhancement of viral infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.03.012

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42222745&oldid=1936249814"